BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3326267)

  • 1. Clinical use of antithrombin III concentrates.
    Vinazzer H
    Vox Sang; 1987; 53(4):193-8. PubMed ID: 3326267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of antithrombin III in shock and DIC: a randomized study.
    Blauhut B; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1985 Jul; 39(1):81-9. PubMed ID: 4035650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
    Wisecarver JL; Haire WD
    Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of DIC with antithrombin III concentrates.
    Sakata Y; Yoshida N; Matsuda M; Aoki N
    Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
    Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
    Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
    Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
    Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III replacement in animal models of acquired antithrombin III deficiency.
    Emerson TE
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
    Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
    Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin (AT) substitution: sense or nonsense?
    Köhler M
    Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.